Work

Direct thrombin inhibition during pulmonary vein isolation using pulsed field ablation

Year: 2025

Type: article

Abstract: Bivalirudin reversibly inhibits circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation with a predictable antithrombotic response.1 Some reports have described its use during catheter-based arrhythmia ablation procedures using thermal energy, including pulmonary vein isolation (PVI) for atrial fibrillation (AF) treatment.2–5

Source: HeartRhythm Case Reports

DOI: 10.1016/j.hrcr.2025.04.020

Authors: Beatriz Jáuregui, Carlos López-Perales, Naiara Calvo, Antonio Asso

Institutions: Universidad de Zaragoza, Hospital Universitario Miguel Servet, IDCQ Hospitales y Sanidad, S.L.U.

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,100